+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Deep Brain Stimulation Devices Market by Product Type, Component, Waveform, Battery Type, Application, End User, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5206441
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Deep Brain Stimulation Devices Market is projected to reach USD 1.87 Billion in 2026. It is expected to continue growing at a CAGR of 10.64%, reaching USD 3.46 Billion by 2032.

Deep brain stimulation devices are implantable neuromodulation systems that deliver controlled electrical pulses to targeted brain structures through implanted leads, an implantable pulse generator, and clinician-programmed software. DBS is an established therapy for movement disorders such as Parkinson's disease, essential tremor, and dystonia, with additional regulated use in select cases of epilepsy and obsessive-compulsive disorder.

Market demand is supported by the rising burden of neurological disease, aging populations, and the clinical need for therapies when medication response becomes inconsistent or adverse effects limit treatment. Modern DBS systems are increasingly defined by directional leads, rechargeable batteries, sensing-enabled pulse generators, MRI-conditional labeling, and digital programming platforms that improve personalization, follow-up efficiency, and long-term therapy management.

Transformative Shifts Reshaping DBS Devices

The DBS landscape is shifting from fixed stimulation hardware toward personalized, data-informed neuromodulation. Directional stimulation has improved current steering, helping clinicians widen the therapeutic window while reducing stimulation-related adverse effects. Rechargeable implantable pulse generators are gaining relevance for patients who require higher energy settings, while compact nonrechargeable systems remain important where simplicity and lower maintenance are priorities.

Care delivery is also changing. Remote programming capabilities, image-guided planning, and integrated patient management tools are reducing the operational burden on specialized centers. Competitive differentiation is increasingly tied to evidence quality, battery longevity, lead design, software usability, MRI access, cybersecurity readiness, and payer confidence in durable outcomes rather than device implantation alone.

Cumulative Impact of Artificial Intelligence on DBS

Artificial intelligence is creating cumulative value across the DBS pathway, from surgical planning to long-term therapy optimization. AI-assisted imaging, segmentation, and tractography workflows can support target localization and lead placement review, while analytics applied to symptom diaries, wearable data, medication patterns, and neural signals can help clinicians interpret treatment response more objectively.

The most important near-term impact is likely to come from adaptive DBS. Sensing-enabled systems can record local field potentials associated with symptoms, and research programs are using machine learning to refine stimulation parameters in response to patient-specific biomarkers. These advances do not replace specialist judgment, but they can reduce trial-and-error programming, improve battery efficiency, and support more consistent symptom control when validated through rigorous clinical evidence, data governance, and regulatory review.

Regional Insights Across DBS Adoption

North America remains a leading region for DBS adoption due to established neurosurgical centers, FDA-regulated device pathways, favorable specialist availability, and strong reimbursement infrastructure for approved indications. Europe shows broad clinical maturity, supported by university hospitals, national health systems, and active research networks, although access can vary by country-level budgeting, referral pathways, and health technology assessment decisions.

Asia-Pacific is expanding as China, Japan, South Korea, Australia, and India invest in advanced neurology care, hospital modernization, and domestic device capabilities. Latin America is progressing through private hospital networks and major urban centers, led by Brazil and Mexico, but uneven reimbursement and specialist concentration limit wider access. The Middle East is building DBS capacity through tertiary hospitals and medical excellence programs in GCC markets, while Africa remains underserved, with adoption concentrated in a small number of specialist centers and constrained by workforce availability, affordability, imaging access, and referral infrastructure.

Group Insights Shaping DBS Access and Innovation

The G7 plays a central role in DBS innovation because it combines high research intensity, mature regulatory systems, established reimbursement pathways, and strong academic neurosurgery networks in the United States, Canada, Japan, Germany, France, Italy, and the United Kingdom. The European Union supports evidence generation and market access through coordinated medical device regulation, clinical evaluation expectations, post-market surveillance requirements, and cross-border research collaboration, even as implementation differs across member states.

BRICS markets are increasingly important to DBS access expansion, especially China and India, where neurological disease burden, patient volume, and hospital investment are rising. ASEAN demand is developing through Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, with access concentrated in advanced private and public referral centers. GCC countries are investing in high-acuity neuroscience services, international clinical partnerships, and tertiary care infrastructure, while NATO markets collectively reinforce procurement standards, cybersecurity expectations, supply chain resilience, and clinical training exchange across advanced health systems.

Country-Level Insights for DBS Devices

The United States is the most influential DBS market, supported by FDA-cleared systems, broad specialist networks, established reimbursement for approved indications, and strong clinical trial activity. Canada benefits from universal health coverage and experienced movement disorder programs but faces provincial access differences and wait-time pressures. Mexico and Brazil show growing adoption in major metropolitan hospitals, while reimbursement, specialist availability, and concentration of advanced neurosurgical infrastructure remain decisive constraints across Latin America.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain advanced DBS programs supported by specialist movement disorder teams, stereotactic neurosurgery capabilities, and public health systems, with Germany and France standing out for engineering depth and clinical research. Russia has specialist neurosurgical capacity but faces procurement and technology access challenges. China is scaling DBS through hospital modernization, clinical research, and domestic innovation; India is growing on the strength of medical expertise, patient volume, and expanding private tertiary care; Japan and South Korea remain advanced technology adopters with strong precision medicine capabilities; and Australia combines high clinical standards with concentrated specialist access through major urban referral centers.

Actionable Recommendations for DBS Industry Leaders

Industry leaders should prioritize evidence-backed differentiation. The strongest commercial strategies will combine long-term outcomes data, patient-reported outcomes, real-world evidence, and clear economic value for payers. Manufacturers should invest in programming efficiency, MRI access, battery longevity, directional stimulation, sensing capabilities, interoperability, and clinician-friendly software because these factors directly influence adoption, center productivity, and long-term patient management.

Companies should also localize market access strategies. Mature markets require rigorous clinical evidence, cybersecurity readiness, post-market surveillance, training support, and service reliability, while emerging markets need education programs, financing support, distributor quality, local regulatory expertise, and partnerships with tertiary hospitals. AI-enabled and adaptive DBS programs should be advanced through transparent validation, human-in-the-loop workflows, privacy safeguards, and early regulatory engagement to build clinician trust and avoid overclaiming performance.

Research Methodology

This executive summary is based on structured secondary research and expert interpretation of verified industry sources, including regulatory databases, peer-reviewed clinical literature, neurology and neurosurgery guidelines, public health data, reimbursement references, hospital technology adoption trends, and medical device safety communications. Emphasis was placed on approved and clinically established indications, validated device features, documented care pathways, and observable regional access patterns.

The analysis applies triangulation across regulatory status, clinical evidence, technology evolution, competitive positioning, and market access dynamics. Insights were reviewed for consistency with known DBS care pathways, including patient selection, stereotactic implantation, imaging-based planning, post-operative programming, follow-up burden, battery replacement considerations, and long-term device management. Forward-looking statements are framed around documented technology trajectories rather than speculative market claims.

Conclusion: Strategic Outlook for DBS Devices

The deep brain stimulation devices market is entering a more sophisticated phase in which outcomes depend on integrated hardware, software, data, and clinical service models. Established use in movement disorders provides a strong foundation, while sensing-enabled platforms, remote care, and AI-supported programming are expanding the potential for more personalized therapy.

Adoption will be strongest where device innovation is matched by reimbursement, trained multidisciplinary teams, responsible data practices, and robust evidence generation. Organizations that combine proven clinical performance with accessible care models, regional market discipline, service reliability, and responsible AI integration will be best positioned to lead the next stage of DBS adoption.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Deep Brain Stimulation Devices Market, by Product Type
7.1. Dual-Channel Deep Brain Stimulators
7.2. Single-Channel Deep Brain Stimulators
8. Deep Brain Stimulation Devices Market, by Component
8.1. Extension Wires
8.2. Implantable Pulse Generator (IPG)
8.3. Leads
8.3.1. Directional Leads
8.3.2. Omnidirectional Leads
8.4. Programmers
8.4.1. Clinician Programmer
8.4.2. Patient Programmer
9. Deep Brain Stimulation Devices Market, by Waveform
9.1. Adaptive Stimulation
9.2. Constant Stimulation
10. Deep Brain Stimulation Devices Market, by Battery Type
10.1. Non-Rechargeable
10.2. Rechargeable
11. Deep Brain Stimulation Devices Market, by Application
11.1. Chronic Pain
11.2. Depression
11.3. Dystonia
11.4. Epilepsy
11.5. Essential Tremor
11.6. Obsessive-Compulsive Disorder (OCD)
11.7. Parkinson’s Disease
11.8. Tourette Syndrome
12. Deep Brain Stimulation Devices Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Hospitals
12.3. Neurological Clinics
12.4. Research Centers
13. Deep Brain Stimulation Devices Market, by Distribution Channel
13.1. Offline
13.2. Online
14. Asia-Pacific Deep Brain Stimulation Devices Market
15. North America Deep Brain Stimulation Devices Market
16. Latin America Deep Brain Stimulation Devices Market
17. Europe Deep Brain Stimulation Devices Market
18. Middle East Deep Brain Stimulation Devices Market
19. Africa Deep Brain Stimulation Devices Market
20. ASEAN Deep Brain Stimulation Devices Market
21. GCC Deep Brain Stimulation Devices Market
22. European Union Deep Brain Stimulation Devices Market
23. BRICS Deep Brain Stimulation Devices Market
24. G7 Deep Brain Stimulation Devices Market
25. NATO Deep Brain Stimulation Devices Market
26. United States Deep Brain Stimulation Devices Market
27. Germany Deep Brain Stimulation Devices Market
28. China Deep Brain Stimulation Devices Market
29. Japan Deep Brain Stimulation Devices Market
30. United Kingdom Deep Brain Stimulation Devices Market
31. India Deep Brain Stimulation Devices Market
32. Canada Deep Brain Stimulation Devices Market
33. Russia Deep Brain Stimulation Devices Market
34. Brazil Deep Brain Stimulation Devices Market
35. Italy Deep Brain Stimulation Devices Market
36. Mexico Deep Brain Stimulation Devices Market
37. France Deep Brain Stimulation Devices Market
38. Spain Deep Brain Stimulation Devices Market
39. Australia Deep Brain Stimulation Devices Market
40. South Korea Deep Brain Stimulation Devices Market
41. Competitive Landscape
41.1. Market Concentration Analysis, 2025
41.1.1. Concentration Ratio (CR)
41.1.2. Herfindahl Hirschman Index (HHI)
41.2. Recent Developments & Impact Analysis, 2025
41.3. Product Portfolio Analysis, 2025
41.4. Benchmarking Analysis, 2025
42. Company Profiles
42.1. Abbott Laboratories
42.2. Aleva Neurotherapeutics SA
42.3. Beijing Pinchi Medical Equipment Co., Ltd.
42.4. Boston Scientific Corporation
42.5. BrainsWay Ltd.
42.6. Fisher Wallace Laboratories LLC
42.7. LivaNova PLC
42.8. Medtronic plc
42.9. Neuro Device Group S.A.
42.10. Neuroelectrics Barcelona S.L.U.
42.11. Neuropace, Inc.
42.12. Neurosoft LLC
42.13. Nexstim Oyj
42.14. Renishaw plc
42.15. Soterix Medical Inc.
List of Figures
FIGURE 1. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 27. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 39. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 51. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 52. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 65. AUSTRALIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 66. SOUTH KOREA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DUAL-CHANNEL DEEP BRAIN STIMULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DUAL-CHANNEL DEEP BRAIN STIMULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DUAL-CHANNEL DEEP BRAIN STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SINGLE-CHANNEL DEEP BRAIN STIMULATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SINGLE-CHANNEL DEEP BRAIN STIMULATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SINGLE-CHANNEL DEEP BRAIN STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EXTENSION WIRES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EXTENSION WIRES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL EXTENSION WIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMPLANTABLE PULSE GENERATOR (IPG) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMPLANTABLE PULSE GENERATOR (IPG) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMPLANTABLE PULSE GENERATOR (IPG) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL LEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL LEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL LEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DIRECTIONAL LEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DIRECTIONAL LEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIRECTIONAL LEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL OMNIDIRECTIONAL LEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL OMNIDIRECTIONAL LEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL OMNIDIRECTIONAL LEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PROGRAMMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PROGRAMMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PROGRAMMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CLINICIAN PROGRAMMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CLINICIAN PROGRAMMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CLINICIAN PROGRAMMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PATIENT PROGRAMMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PATIENT PROGRAMMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PATIENT PROGRAMMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ADAPTIVE STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ADAPTIVE STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ADAPTIVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CONSTANT STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CONSTANT STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CONSTANT STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NON-RECHARGEABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NON-RECHARGEABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NON-RECHARGEABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RECHARGEABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RECHARGEABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RECHARGEABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DEPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DEPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DEPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DYSTONIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DYSTONIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DYSTONIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ESSENTIAL TREMOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL OBSESSIVE-COMPULSIVE DISORDER (OCD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL OBSESSIVE-COMPULSIVE DISORDER (OCD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL OBSESSIVE-COMPULSIVE DISORDER (OCD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TOURETTE SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TOURETTE SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TOURETTE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NEUROLOGICAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NEUROLOGICAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NEUROLOGICAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RESEARCH CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL RESEARCH CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL RESEARCH CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 132. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 135. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. EUROPE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 152. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 153. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 154. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 155. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 156. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. AFRICA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 161. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 162. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 163. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 165. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 166. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. ASEAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 172. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 173. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 174. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 175. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 176. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. GCC DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 192. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 193. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 194. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 195. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 196. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. BRICS DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 199. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 202. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 203. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 204. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 205. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 206. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. G7 DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 211. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 212. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 213. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 214. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 215. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 216. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. NATO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 232. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 233. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 234. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 235. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 236. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. GERMANY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 240. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 241. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 242. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 243. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 244. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 245. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 246. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. CHINA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 249. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 250. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 252. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 253. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 254. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 255. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 256. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 257. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. JAPAN DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 259. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 260. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 263. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 264. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 266. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 269. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 270. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 271. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 272. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 273. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 274. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 275. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 276. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 277. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. INDIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 279. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 280. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 281. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 282. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 283. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 284. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 285. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 286. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. CANADA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 289. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 290. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 291. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 292. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 293. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 294. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 295. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 296. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 297. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 298. RUSSIA DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 299. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 300. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 301. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 302. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 303. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 304. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 305. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 306. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 308. BRAZIL DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 309. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 310. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 311. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 312. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 313. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 314. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 315. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 316. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 317. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 318. ITALY DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 319. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 320. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 321. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 322. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 323. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 324. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 325. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 326. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 327. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 328. MEXICO DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 329. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 330. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 331. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 332. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY LEADS, 2018-2032 (USD MILLION)
TABLE 333. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY PROGRAMMERS, 2018-2032 (USD MILLION)
TABLE 334. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY WAVEFORM, 2018-2032 (USD MILLION)
TABLE 335. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY BATTERY TYPE, 2018-2032 (USD MILLION)
TABLE 336. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 337. FRANCE DEEP BRAIN STIMULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 338. FRANCE DEEP BRAIN STIMULAT

Companies Mentioned

The companies featured in this Deep Brain Stimulation Devices market report include:
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing Pinchi Medical Equipment Co., Ltd.
  • Boston Scientific Corporation
  • BrainsWay Ltd.
  • Fisher Wallace Laboratories LLC
  • LivaNova PLC
  • Medtronic plc
  • Neuro Device Group S.A.
  • Neuroelectrics Barcelona S.L.U.
  • Neuropace, Inc.
  • Neurosoft LLC
  • Nexstim Oyj
  • Renishaw plc
  • Soterix Medical Inc.

Table Information